Common bone drugs linked to esophageal cancer risk

LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday. --- Common bone drugs linked to esophageal cancer risk
Osteoporosis: Is Treatment Worse than the Disease? Food Consumer
MedPage Today - The Associated Press - Telegraph.co.uk
Study cautions over longterm use of osteoporosis drugs and cancer risk